Increasing Regulatory Barriers May Threaten US Medical Innovation | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Tuesday, March 29, 2011

Email

Comments

Ocular Surgery News

Mounting U.S. Food and Drug Administration regulations imposed on new medical technologies may jeopardize the standards of care in the United States, according to a presenter here.

All of the following are true of primary Sjogren Syndrome except:
1. Most commonly found in elderly males
2. No associated connective tissue disease
3. 90% HLA-B8 haplotype +
4. Associated with anti-La (SS-B) autoantibodies
Check The Answer

3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product
SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us